IMA Advisory Services’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
BBA
IMA Advisory Services's ALXN Position: Q1 2019 in Review
IMA Advisory Services sold out of Alexion Pharmaceuticals (ALXN) in Q1 2019, closing a stake of 54 shares — an estimated $5K sold.
IMA Advisory Services first reported a position in ALXN in Q2 2018 and held it in 3 quarters. The position peaked at $10K in Q2 2018. 611 funds tracked by Wall St. Rank hold ALXN as of Q1 2019.
- IMA Advisory Services reported no remaining Alexion Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
- IMA Advisory Services sold 54 Alexion Pharmaceuticals shares in Q1 2019, an estimated $5K.
- IMA Advisory Services first reported a position in Alexion Pharmaceuticals in Q2 2018 and held it in 3 quarters.
- IMA Advisory Services's Alexion Pharmaceuticals position peaked at $10K in Q2 2018.
- 611 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2019.
Based on IMA Advisory Services's 13F filing for Q1 2019, filed 9 May 2019.